Literature DB >> 18091026

Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension.

James Tolle1, Aaron Waxman, David Systrom.   

Abstract

PURPOSE: To determine the relative contributions of the Fick principle variables to impaired exercise tolerance in pulmonary arterial hypertension compared with pulmonary venous hypertension.
METHODS: One hundred forty-seven consecutive, complete, clinically indicated cardiopulmonary exercise tests done with radial and pulmonary arterial catheters and radionuclide ventriculographic scanning were screened for an exercise limit attributable to 1) pulmonary arterial hypertension (N = 34), 2) left ventricular systolic (N = 23), or 3) diastolic dysfunction (N = 36), defined by mean pulmonary artery pressure, pulmonary capillary wedge pressure, and left ventricular ejection fraction. Systolic and diastolic dysfunction are together referred to as pulmonary venous hypertension. Patients with other limits were excluded, including those with a pulmonary mechanical limit. For the resulting 93 exercise tests, the Fick principle variables' contributions to a depressed maximum oxygen consumption were compared by ANOVA and ANCOVA.
RESULTS: Maximum oxygen consumption (54.5 +/- 15.5 vs 73.2 +/- 20.1 vs 66.0 +/- 15.7% predicted) and oxygen delivery (1457 +/- 456 vs 2161 +/- 824 vs 2007 +/- 665 mL x min(-1)) were reduced in systolic dysfunction versus both diastolic dysfunction and pulmonary arterial hypertension, respectively (P < 0.05 by ANOVA). Maximum systemic oxygen extraction ratio was highest in systolic dysfunction, intermediate in diastolic dysfunction, and lowest in pulmonary arterial hypertension (0.744 +/- 0.091 vs 0.680 +/- 0.091 vs 0.619 +/- 0.113, respectively, P < 0.05 among all groups). Systemic oxygen extraction at peak exercise was inversely related to maximum cardiac output in pulmonary arterial hypertension, but it was blunted versus systolic dysfunction throughout the range of peak cardiac outputs (P < 0.05 by ANCOVA).
CONCLUSIONS: Maximum systemic oxygen extraction is impaired in pulmonary arterial versus pulmonary venous hypertension and contributes to the exercise limit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18091026     DOI: 10.1249/mss.0b013e318159d1b8

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  17 in total

1.  Detection of exercise-induced pulmonary arterial hypertension by cardiopulmonary exercise testing.

Authors:  Martin Schwaiblmair; Christian Faul; Wolfgang von Scheidt; Thomas M Berghaus
Journal:  Clin Cardiol       Date:  2012-05-15       Impact factor: 2.882

Review 2.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

3.  Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension.

Authors:  Priscila B Barbosa; Eloara M V Ferreira; Jaquelina S O Arakaki; Luciana S Takara; Juliana Moura; Rúbia B Nascimento; Luiz E Nery; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2011-01-12       Impact factor: 3.078

4.  Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.

Authors:  Simon Malenfant; François Potus; Frédéric Fournier; Sandra Breuils-Bonnet; Aude Pflieger; Sylvie Bourassa; Ève Tremblay; Benjamin Nehmé; Arnaud Droit; Sébastien Bonnet; Steeve Provencher
Journal:  J Mol Med (Berl)       Date:  2014-12-30       Impact factor: 4.599

5.  Unexplained exertional intolerance associated with impaired systemic oxygen extraction.

Authors:  Kathryn H Melamed; Mário Santos; Rudolf K F Oliveira; Mariana Faria Urbina; Donna Felsenstein; Alexander R Opotowsky; Aaron B Waxman; David M Systrom
Journal:  Eur J Appl Physiol       Date:  2019-09-06       Impact factor: 3.078

6.  The effects of pulmonary hypertension on skeletal muscle oxygen pressures in contracting rat spinotrapezius muscle.

Authors:  Kiana M Schulze; Ramona E Weber; Trenton D Colburn; Andrew G Horn; Carl J Ade; Wei-Wen Hsu; David C Poole; Timothy I Musch
Journal:  Exp Physiol       Date:  2021-09-17       Impact factor: 2.858

7.  Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension.

Authors:  Irina Enache; Anne-Laure Charles; Jamal Bouitbir; Fabrice Favret; Joffrey Zoll; Daniel Metzger; Monique Oswald-Mammosser; Bernard Geny; Anne Charloux
Journal:  Mol Cell Biochem       Date:  2012-10-26       Impact factor: 3.396

8.  The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care.

Authors:  Ahmad Sabbahi; Richard Severin; Cemal Ozemek; Shane A Phillips; Ross Arena
Journal:  Expert Rev Respir Med       Date:  2020-01-03       Impact factor: 3.772

9.  Effects of pulmonary hypertension on microcirculatory hemodynamics in rat skeletal muscle.

Authors:  Kiana M Schulze; Ramona E Weber; Andrew G Horn; Trenton D Colburn; Carl J Ade; David C Poole; Timothy I Musch
Journal:  Microvasc Res       Date:  2022-01-30       Impact factor: 3.514

10.  Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.

Authors:  Kevin White; Yu Lu; Sofia Annis; Andrew E Hale; B Nelson Chau; James E Dahlman; Craig Hemann; Alexander R Opotowsky; Sara O Vargas; Ivan Rosas; Mark A Perrella; Juan C Osorio; Kathleen J Haley; Brian B Graham; Rahul Kumar; Rajan Saggar; Rajeev Saggar; W Dean Wallace; David J Ross; Omar F Khan; Andrew Bader; Bernadette R Gochuico; Majed Matar; Kevin Polach; Nicolai M Johannessen; Haydn M Prosser; Daniel G Anderson; Robert Langer; Jay L Zweier; Laurence A Bindoff; David Systrom; Aaron B Waxman; Richard C Jin; Stephen Y Chan
Journal:  EMBO Mol Med       Date:  2015-06       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.